Evidence map›Paper›PMID 31581166›Full record

ArticleMMWR. Morbidity and mortality weekly report2019

E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury - Illinois and Wisconsin, April-September 2019.

Isaac Ghinai, Ian W Pray, Livia Navon, Kevin O'Laughlin, Lori Saathoff-Huber, Brooke Hoots, Anne Kimball, Mark W Tenforde, Jennifer R Chevinsky, Mark Layer and 3 more

Open access · diamondAbstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Literature Review of E-Cigarette-Related Illness and Injury: Not Just for the Respirologist.International journal of environmental research and public health · 2020
    Pooled it
  3. Review
  4. Article
  5. Article
  6. The Importance of Conventional Toxicological Metrics of Aerosol Characterization.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
  7. Article
  8. Article
  9. A case of acute lung injury due to an e-cigarette.Clinical medicine (London, England) · 2022
    Article
  10. Article
  11. Vaping-Associated Lung Injury: A Review.Medicina (Kaunas, Lithuania) · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Environmental Factors.Critical care clinics · 2021
    Review
  18. Article
  19. Review
  20. The chemistry and toxicology of vaping.Pharmacology & therapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Isaac Ghinai
Ian W Pray
Livia Navon
Kevin O'Laughlin
Lori Saathoff-Huber
Brooke Hoots
Anne Kimball
Mark W Tenforde
Jennifer R Chevinsky
Mark Layer
Ngozi Ezike
Jonathan Meiman
Jennifer E Layden

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In July 2019, the Illinois Department of Public Health and the Wisconsin Department of Health Services launched a coordinated epidemiologic investigation after receiving reports of several cases of lung injury in previously healthy persons who reported electronic cigarette (e-cigarette) use, or vaping (1). This report describes features of e-cigarette product use by patients in Illinois and Wisconsin. Detailed patient interviews were conducted by telephone, in person, or via the Internet with 86 (68%) of 127 patients. Overall, 75 (87%) of 86 interviewed patients reported using e-cigarette products containing tetrahydrocannabinol (THC), and 61 (71%) reported using nicotine-containing products. Numerous products and brand names were identified by patients. Nearly all (96%) THC-containing products reported were packaged, prefilled cartridges, and 89% were primarily acquired from informal sources (e.g., friends, family members, illicit dealers, or off the street). In contrast, 77% of nicotine-containing products were sold as prefilled cartridges, and 83% were obtained from commercial vendors. The precise source of this outbreak is currently unknown (2); however, the predominant use of prefilled THC-containing cartridges among patients with lung injury associated with e-cigarette use suggests that they play an important role. While this investigation is ongoing, CDC recommends that persons consider refraining from using e-cigarette, or vaping, products, particularly those containing THC. Given the diversity of products reported and frequency of patients using both THC- and nicotine-containing e-cigarette products, additional methods such as product testing and traceback could help identify the specific cause of this outbreak.

Indexed as

Disease OutbreaksElectronic Nicotine Delivery SystemsAdolescentAdultDronabinolFemaleHumansIllinoisLung InjuryMaleVapingWisconsinYoung AdultDronabinol

Identifiers

PMID31581166
PMCPMC6776374
OpenAlexW2974959546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.